![Health Economics and Genomics](https://i1.feedspot.com/4752684.jpg)
Health Economics and Genomics
304 FOLLOWERS
The purpose of this blog is to provide a forum for the discussion of issues surrounding the health economic analysis of genomic technologies. This blog encourages health economists with an interest in this area to share ideas and discuss the various challenges that arise when applying standard health economic methods in this interesting and rapidly evolving field.
Health Economics and Genomics
1w ago
Two publications this week:
Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada | link
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
3w ago
Two publications this week:
Whole genome sequencing as a ticket to cancer treatment in the Netherlands: Are inequalities in access to molecular diagnostics unfair? | link
Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for pub ..read more
Health Economics and Genomics
1M ago
Two publications this week:
The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs | link
Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
2M ago
One publication this week:
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
2M ago
Two publications this week:
The cost of genetic diagnosis of suspected hereditary pediatric cataracts with whole-exome sequencing from a middle-income country perspective: a mixed costing analysis | link
Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it ..read more
Health Economics and Genomics
2M ago
Two publications this week:
Paving the path for implementation of clinical genomic sequencing globally – Are we ready? | link
Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho)social implications | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
3M ago
One publication this week:
Patient preferences in genetic newborn screening for rare diseases: study protocol | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
3M ago
Two publications this week:
Genomic multidisciplinary teams: A model for navigating genetic mainstreaming and precision medicine | link
Mendelian Randomization analysis of the causal effect of cigarette smoking on hospital costs | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
3M ago
Two publications this week:
Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol | link
Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics ..read more
Health Economics and Genomics
4M ago
Three publications this week:
Targeted genome sequencing for tuberculosis drug susceptibility testing in South Africa: a proposed diagnostic pipeline | link
Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho)social implications | link
Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a T ..read more